课题基金 / 基金详情

Randomized, Placebo-Controlled Study of Olanzapine for the Control of Chemotherapy-induced Vomiting (CIV) in Children Receiving Cyclophosphamide-based Conditioning for Allogeneic Hematopoietic Stem Cell Transplant

Randomized, Placebo-Controlled Study of Olanzapine for the Control of Chemotherapy-induced Vomiting (CIV) in Children Receiving Cyclophosphamide-based Conditioning for Allogeneic Hematopoietic Stem Cell Transplant
奥氮平用于控制接受基于环磷酰胺的同种异体造血干细胞移植调理的儿童化疗引起的呕吐 (CIV) 的随机、安慰剂对照研究
批准号:
333043
负责人:
Dupuis L. L
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-05-01 至 2016-05-01

项目摘要

项目成果

Dupuis L. L的其他基金

相似基金

相关文献

中文摘要
翻译
化疗引起的恶心和呕吐(CINV)是癌症儿童及其父母最痛苦的治疗相关症状之一。即使给儿童注射了预防CINV的药物,仍有大约一半的儿童会感染
英文摘要
Chemotherapy-induced nausea and vomiting (CINV) is one of the most distressing treatment-related symptoms according to children with cancer and their parents. Even when medicines are given to children to prevent CINV, about half of children still experien
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金